SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-17-000770
Filing Date
2017-10-02
Accepted
2017-10-02 16:02:03
Documents
2
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 ss61447_sc13da.htm SC 13D/A 110176
2 JOINT FILING AGREEMENT ss61447_ex9901.htm EX-99.1 13424
  Complete submission text file 0000947871-17-000770.txt   125137
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 20 INDEPENDENCE BOULEVARD WARREN NJ 07059
Business Address 20 INDEPENDENCE BOULEVARD WARREN NJ 07059 908-605-4700
Roka BioScience, Inc. (Subject) CIK: 0001472343 (see all company filings)

IRS No.: 270881542 | State of Incorp.: DE | Fiscal Year End: 1216
Type: SC 13D/A | Act: 34 | File No.: 005-88250 | Film No.: 171114534
SIC: 3826 Laboratory Analytical Instruments